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ABSTRACT OF THE DISSERTATION
Zebrafish Models of KATP Channelopathies
by
Soma Sekhara Singareddy
Doctor of Philosophy in Biomedical Engineering
Washington University in St. Louis, 2022
Professor Colin G. Nichols, Chair

Much work has been carried out to understand the composition, structure, and function of ATPsensitive potassium (KATP) channels in mammalian tissues, as well as the molecular basis of the
channelopathies that result from loss-of-function or gain-of-function mutations in these channels.
These studies have also highlighted that the available pharmacology to treat such diseases is limited.
To overcome such limitations, a better understanding of the tissue specificity of expression, the exact
mechanisms linking the molecular dysfunction to the development of complex pathophysiology, the
potential for reducing cross-reactivity of drugs, and ultimately more specific therapies are needed. The
work described in this thesis initially considers zebrafish as a model organism to further understand
KATP channel physiology, pathology, and pharmacology. Detailed methods are described to isolate
cardiac and vascular myocytes for patch-clamp studies. Using these methods, the molecular make-up
and properties of zebrafish atrial, ventricular and vascular smooth muscle KATP channels are described,
showing that the subunit expression is the same as in equivalent mammalian tissues, validating
zebrafish as relevant models of human Cantu Syndrome. Additional studies reveal previously
unrecognized secondary consequences of genetic manipulation of KATP channels – including decreased
KATP channel expression in the case of a gain-of-function neonatal diabetes mutation and the upregulation of an unknown large-conductance ATP-insensitive K+ channel accompanying KATP downregulation in pancreatic β-cells – providing novel hypotheses that may help to explain associated KATP
channelopathies.

vii

Chapter 1
Introduction
Bioelectricity is key to life on this planet. A cell is just an insentient bag of chemicals until it establishes
a membrane potential, and scientific efforts in measuring bioelectricity have substantially advanced
our understanding of the field of biology (Malmivuo & Plonsey, 1995). By developing a feedback
control device using vacuum tube operational amplifiers (designed during the WWII era), Alan
Hodgkin and Andrew Huxley were able to control the transmembrane voltage in the squid giant axon
and measure the membrane currents that underlie the propagating nerve impulse (Hodgkin & Huxley,
1952c, d; Hodgkin & Huxley, 1952a, b; Hodgkin et al., 1952). This seminal technique, known as the
voltage clamp, and the corresponding mathematical model developed by Hodgkin and Huxley to fit their
observed experimental data, explained the electrical impulse that drives excitable-cell physiology.
Advances in the fields of physics and biochemistry over the next few decades led to much more
sophisticated amplifiers and efficient single-cell dissociation techniques. Utilizing this advanced
technology, Erwin Neher and Bert Sakmann developed a technique, that even after 40 years, continues
to serve as the gold-standard for electrophysiological studies – the patch clamp technique (Neher &
Sakmann, 1976). Development of the patch clamp led to measurement of currents through the
individual macromolecular pores in cell membranes that selectively allow permeation of specific ions
through them in response to polymodal stimuli. These pores, known as ion channels, represent the
second largest protein family (second only to the GPCRs) studied to date (Hutchings et al., 2019).
Advances in molecular cloning, genome sequencing, structural biology, molecular dynamic simulations
and fluorescent imaging techniques, have led to the recognition of thousands of distinct ion channel
protein subunits, and understanding of their molecular mechanisms. Several ion channels are targets
of blockbuster drugs (Kaczorowski et al., 2008), and they may yet serve as impactful targets in
regulating pandemic causing viruses (McClenaghan et al., 2020a).

1

1.1

KATP Channels – Metabolic Transducers of The Cells

Ion channels can be classified based on their ion selectivity, the molecular structure, and the gating
mechanism (i.e., how the opening/closing response of the channel is regulated) (Hille, 2001). ATPsensitive potassium (KATP) channels are K+-selective ion channels that are characteristically inhibited
by intracellular ATP (Nichols, 2006a), such that their activity reflects the metabolic state of the cell.

1.1.1

KATP Channels – Discovery and Expression

The development of enzymatic techniques for isolating individual cardiomyocytes (Bustamante et al.,
1981) led to pioneering studies of individual ion channels in cardiomyocytes. In the early 1980s,
Akinori Noma performed a series of cell-attached patch clamp experiments on cardiomyocytes
isolated from guinea pig and rabbit hearts, and discovered that when the ATP levels were depleted
using CN- to poison the mitochondria, characteristic potassium channel currents were observed.
When a patch of the membrane was excised into the inside-out configuration, activity of these
channels markedly increased but was then reversibly inhibited when sub-millimolar concentrations of
ATP were added to the exposed inner-side of the membrane. Noma called these ionic currents ATPsensitive K+ (KATP) channel currents and this is the first reported characterization of KATP channels in
the literature (Noma, 1983).
KATP channels were subsequently discovered and characterized in the plasma membranes of
multiple tissues, including pancreatic β-cells (Ashcroft et al., 1984), skeletal muscle (Spruce et al., 1985),
neurons (Ashford et al., 1988), smooth muscle (Beech et al., 1993), kidney (Hunter & Giebisch, 1988),
and epithelial cells (Kunzelmann et al., 1989).
1.1.1.1

Cardiac KATP Channels

Opening of KATP channels in the heart drives outward K+ current and hyperpolarizes the cell, thereby
shortening the action potential, and in extreme activation can lead to contractile failure(Lederer &
Nichols, 1989; Lederer et al., 1989). However, despite being the most densely expressed ion channel
in the heart (Foster & Coetzee, 2016), KATP channels seem to play an insignificant role in regulating
2

the cardiac function under normal physiological conditions, as evidenced from studies using genetic
knock-out animals (Suzuki et al., 2001; Suzuki et al., 2002) or gain-of-function transgenic animals (Flagg
& Nichols, 2001). This has led to much discussion of what role KATP channels may play in the heart.
It is often hypothesized that activation of KATP channels may protect cardiac tissue from failure under
ischemic conditions by reducing the contractility, which is supported by studies using genetic knockin mice that have over-active KATP channels in the heart (Nichols & Lederer, 1990b; Suzuki et al., 2001;
Suzuki et al., 2002).
1.1.1.2

Vascular KATP Channels

Isolation of physiologically responsive individual vascular smooth muscle (VSM) cells (Worley et al.,
1986) enabled studies on the role of KATP channels in the vasculature. Similar to cardiac KATP, opening
of vascular KATP drives membrane hyperpolarization and decreases contractility, leading to
vasorelaxation (Brayden, 2002). Under hypoxic conditions, activation of KATP channels may underlie
a vasodilatory response by the arteries (Daut et al., 1990). KATP channels may also play a critical role in
the ischaemic reperfusion of coronary and cerebral blood vessels (Kanatsuka et al., 1992; Bari et al.,
1998). Vasodilation that occurs in response to acidosis and endotoxemia has also in-part been
attributed to the activation of VSM KATP channels (Landry & Oliver, 1992; Ishizaka & Kuo, 1996;
Kinoshita & Katusic, 1997).
1.1.1.3

Pancreatic KATP Channels

Soon after KATP channels were discovered as metabolic sensors by Noma in the heart, multiple groups
focused on the role of these channels in one of the major metabolic regulators of the body, the
pancreas (Ashcroft et al., 1984; Cook & Hales, 1984; Rorsman & Trube, 1985). One of the most
obvious roles of KATP channels is in the pancreatic β-cells, where they mediate the glucose-stimulated
insulin secretion (Koster & Nichols, 2002). Closure of KATP channels in response to elevated β-cell
ATP-levels depolarizes the membrane and initiates action potential firing (Rorsman et al., 2011), which
in turn activates voltage-gated Ca2+ channels that trigger insulin secretion (Schulla et al., 2003; Braun
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et al., 2008). KATP channels are also implicated in the function of pancreatic α-cells, which release
glucagon in response to lowered blood glucose levels (Gromada et al., 2004; Munoz et al., 2005; Shiota
et al., 2005), although the exact mechanism remains unclear.

1.1.2

KATP Channels – Composition and Structure

Cloning of the Shaker K+ channel gene from Drosophila melanogaster in the late 1980s (Baumann et al.,
1987; Kamb et al., 1987; Papazian et al., 1987; Tempel et al., 1987) and subsequent reconstitution studies
(Iverson et al., 1988; Timpe et al., 1988) paved the way for detailed biophysical characterization of
various K+ channel subunits. The seminal work of structural biologists in resolving the first-ever
crystal structure of a potassium channel (KcsA) in the late 1990s (Doyle et al., 1998; MacKinnon et al.,
1998) not only helped visualize and understand the nature of potassium selectivity engendered by the
classical Gly-Tyr-Gly or Gly-Phe-Gly sequence that is common to all K+ channels, but also triggered
subsequent structural studies of various other ion channels.
1.1.2.1

Cloning of KATP Genes

In the early 1990s, using expression cloning techniques, the first Kir channels were cloned (Ho et al.,
1993; Kubo et al., 1993), which led to the subsequent homology-based cloning of a whole subfamily
of this structural class (Nichols & Lopatin, 1997). At the same time, Joe Bryan and colleagues purified
sulfonylurea receptor (SUR1) proteins using radio-labelled sulfonylurea analogues, and then cloned
the underlying ABCC8 gene (Aguilar-Bryan et al., 1995), and together with Susumu Seino and
colleagues carried out now-classic experiments in which all the properties of native KATP channels
were recapitulated, when SUR1 was co-expressed with Kir6.2 subunits (Inagaki et al., 1995a; Sakura et
al., 1995). Further cloning studies confirmed two isoforms of Kir6 (Kir6.1 and Kir6.2) and two
isoforms of SURs (SUR1 and SUR2 with two major splice variants, SUR2A and SUR2B) (Inagaki et
al., 1996; Isomoto et al., 1996; Yamada et al., 1997). SUR1 and Kir6.2 are encoded by the gene pairs
ABCC8 and KCNJ11, respectively, adjacent to one another on chromosome 11p15.1, while and SUR2
and Kir6.1 (ABCC9 and KCNJ8, respectively) are on chromosome 12p12.1, in the human genome
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(Inagaki et al., 1995b; Chutkow et al., 1996). Subsequent biophysical analysis of channels formed by
subunit mixing as well biochemical analysis of complex molecular weight (Clement et al., 1997; Shyng
& Nichols, 1997), indicated that native KATP channels are hetero-octamers formed by four Kir6
subunits and four SUR subunits (Figure 1.1).
Even though transcripts for each channel subunit are frequently detectable in various isolated
tissues, the functional behaviour of KATP channels is typically characteristic of a specific subunit
pairing (Figure 1.1). For example, the purported channel composition in pancreatic β cells and neurons
is Kir6.2/SUR1(Ashcroft et al., 1987; Aguilar-Bryan et al., 1995), based on high single-channel
conductance (Kir6.2 ~80pS in 140mM K+) and high sensitivity to both glibenclamide and the
SUR1/SUR2B-specific KATP channel activator diazoxide. Similarly, in smooth muscles the purported
channel composition is Kir6.1/SUR2B, based on low single channel conductance (Kir6.1 ~35pS in
140mM K+) and sensitivity to diazoxide (Cui et al., 2002) and in striated muscles is Kir6.2/SUR2A,
based on high single-channel conductance (Kir6.2 ~80pS in 140mM K+), low sensitivity to
glibenclamide and activation by the SUR2A -specific KATP channel activator pinacidil (Bao et al., 2011).
1.1.2.2

Structural Studies of KATP Channels

KATP channels are large protein complex (~950 kDa), and no crystal structure of the channels has yet
been determined using X-ray crystallography (Martin et al., 2020). Beginning in the early 1980s, using
transmission electron microscopy on samples frozen to cryogenic temperatures, cryogenic electron
microscopy (cryo-EM) provided an alternative to X-ray crystallography for near-atomic resolution of
protein structures (Dubochet & McDowall, 1981; Adrian et al., 1984). In 2005, by fusing the Cterminus of SUR1 with the N-terminus of Kir6.2, the first three-dimensional KATP structure was
obtained using single-particle negative stain cryo-EM (Mikhailov et al., 2005). The resolution was too
low to resolve molecular details, but it confirmed a central tetrameric Kir6.2 core appended by four
SUR1 subunits. Revolutionary technological improvement in electron detection, camera readouts, and
computational methods have recently improved cryo-EM to routinely produce structures with nearcrystallographic resolutions (Cheng, 2015; Cheng et al., 2015). This has opened up sub-nanometre
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resolution structural studies in KATP channels in 2017 and several groups have now published
convincing structures of KATP channels in closed configurations (Martin et al., 2017a, 2017b, 2019;
Ding et al., 2019; Lee et al., 2017; Li et al., 2017; Wu et al., 2018). Very recently, the molecular structures
of KATP channels in their non-pharmacological open configuration have also been resolved (Sung et
al., 2021; Zhao & MacKinnon, 2021), providing further insights into the gating mechanism of KATP
channels.

1.1.3

KATP Channels – Molecular Function

The structure of Kir6.2 closely resembles that of the eukaryotic Kir3.2 (Whorton & Mackinnon, 2011),
with the inner and outer helices forming a critical constriction and causing pore-closure at the
cytoplasmic domain (Whorton & Mackinnon, 2011; Lee et al., 2017; Li et al., 2017b; Martin et al., 2017).
It can be extrapolated that the mechanism of K+ selectivity and pore gating in KATP channels are
broadly similar to that in other Kir channels. However, unlike other Kir channels, KATP channels do
not show a pronounced inward-rectification. Inward-rectification is the voltage-dependent block of
ion permit into the cell, across the pore, by cytoplasmic divalent cations such as magnesium and
cellular polyamines (Lopatin et al., 1994; Nichols et al., 1994; Lopatin et al., 1995). The occlusion of ion
movement by polyamines typically determines the strength of inward-rectification and KATP channels
show little sensitivity to polyamines (Yamada & Kurachi, 1995), perhaps due to the lack of acidic
residues at the purported polyamine binding site, and this is a possible cause of their ‘weak’ inwardrectification.
1.1.3.1

Physiological Regulators of KATP Channels

Initial insights to the conduction and gating of KATP channels were provided by biophysical models
(Enkvetchakul & Nichols, 2003). Inhibition of channel gating by cytoplasmic ATP is the signature
property of KATP channels. Residues in the cytosolic domain of the pore-forming Kir6 subunit are key
to this property and this inhibition can be achieved in the absence of SUR subunit (Tucker et al., 1997).
However, the SUR1 subunit does allosterically enhance the ATP sensitivity of KATP channels by ~106

fold. Kir6.1 is slightly less sensitive to ATP inhibition than Kir6.2 (Babenko & Bryan, 2001; Cui et al.,
2002). Site-directed mutagenesis implicated several key residues for ATP-binding in the Kir6 domain
(Reimann et al., 1999; John et al., 2003; Trapp et al., 2003; Antcliff et al., 2005) and based on the
structural information, ATP binds to Kir6 subunit in a horseshoe-shaped pocket defined by the
residues 182-185 (IFSK) and 332-335 (KFGN) (Lee et al., 2017). ATP also forms hydrogen bonds
with the N48 and R50 residues in the neighbouring Kir6 subunit of the tetramer. The KATP channel
complex binds to four molecules of ATP, one in each subunit, but binding of a single ATP is also
sufficient to cause a closed confirmation of the channel (Vanoye et al., 2002; Enkvetchakul & Nichols,
2003).
KATP channels are also regulated by intracellular ADP. In the absence of Mg2+ or of SUR
subunits, ADP inhibits channel activity, presumably by binding to the same ATP-inhibitory site
(Nichols et al., 1990; Nichols & Lederer, 1990a). In the presence of Mg2+ and SUR subunits, ADP
increases KATP channel open probability (Po). Activation of KATP channels by MgADP is determined
by macromolecular interactions between the Nucleotide Binding Domains (NBD1 and NBD2) of the
SUR subunit (Gribble et al., 1997a; Shyng et al., 1997). NBD1 interacts with NBD2 to form an
asymmetric functional unit that hydrolyses MgATP. Based on biochemical studies, NBD1 binds the
intracellular nucleotides with slow hydrolysis whilst NBD2 binds Mg2+-nucleotides with rapid
hydrolysis (Ueda et al., 1997; Bienengraeber et al., 2000; de Wet et al., 2007), increasing the channel
activity (Zingman et al., 2001). Excised patch-clamp recordings show that application of MgADP in
the presence of ATP can stimulate the channel potentially by trapping the ‘activated’ post-hydrolytic
state (Bienengraeber et al., 2000; Masia et al., 2005), since non-hydrolysable nucleotides can also cause
conformational changes in the NBDs (Ortiz et al., 2013). In cryo-EM structures of the closed channels,
the NBDs are separate and asymmetric relative to each other (Li et al., 2017b; Martin et al., 2017).
However, in the more recently resolved open-state structures, the NBDs seem to align and dimerize
(Sung et al., 2021; Zhao & MacKinnon, 2021).
Besides this signature nucleotide regulation, other physiological ligands modulate KATP channel
gating through direct interaction with the channel subunits. Membrane phospholipids such as
7

phosphatidylinositol 4,5-bisphosphate (PIP2), stimulate KATP channels by binding to the Kir6 subunit
(Fan & Makielski, 1997; Baukrowitz et al., 1998; Shyng & Nichols, 1998; Quinn et al., 2003; Ribalet et
al., 2005; Xie et al., 2008), and addition of exogenous PIP2 to the cytosolic domain of the KATP channels
can recover maximal channel activity following the run-down that occurs post-excision of the
membrane. In contrast, application of phospholipase C (PLC), which hydrolyses PIP2, reduces KATP
channel activity significantly (Hilgemann & Ball, 1996; Fan & Makielski, 1997). Interestingly, there is
an inverse correlation between PIP2-dependent activation and ATP-dependent inhibition of KATP
channels, in that as PIP2 increases, channel Po increases and ATP-sensitivity decreases (Enkvetchakul
& Nichols, 2003). Similar to PIP2, long-chain acyl-coA molecules (LC-CoA) are also known to
modulate KATP channel activity (Liu et al., 2001). This implies that ATP sensitivity in vivo may be
critically dependent on membrane lipid composition, in addition to nucleotide levels.
Acidic intracellular pH conditions can stimulate KATP channel activity (Davies, 1990; Davies et
al., 1992; Xu et al., 2001). The exact mechanism of the pH-mediated regulation of KATP activity is not
clear, but it is generally understood that protons decrease ATP-sensitivity (Wu et al., 2002; Cui et al.,
2006). In smooth-muscle and pancreatic KATP channels, protein kinase A (PKA) phosphorylation has
been shown to increase Po, although there is no consensus on the phosphorylation sites (Beguin et al.,
1999; Lin et al., 2000). In ventricular KATP channels, protein kinase C (PKC) has mixed regulatory
properties, inhibiting the channel activity at micromolar ATP concentrations (Light et al., 1995), and
activating at higher ATP concentrations (Light et al., 1996).
1.1.3.2

Pharmacological Regulators of KATP Channels

Inhibition by sulfonylurea drugs is a marked feature of KATP channels (Aguilar-Bryan et al., 1995). Early
recombinant expression studies on Kir6.2/SUR1 KATP channels using sulfonylureas and related
compounds helped establish a biphasic dose-response curve that indicates two independent binding
sites of different affinities (Gribble et al., 1997b; Gribble & Ashcroft, 1999; Hansen et al., 2002). The
high-affinity binding site is on the SUR and the low affinity site on the pore-forming Kir6 subunit
(Gribble et al., 1997b; Ashfield et al., 1999). SUR1 and SUR2 exhibit different sensitivities to the
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sulfonylurea-mediated inhibition. SUR1 and SUR2B containing channels show high affinity for
glibenclamide, glimepiride, repaglinide, and meglitinide, whereas, SUR2-containing channels do not
exhibit high-affinity for tolbutamide, gliclazide, chlorpropamide, and nateglinide do not exhibit highaffinity to SUR2-containing channels (Gribble & Reimann, 2003). Studies involving SUR1 and SUR2
chimeras suggest that residue S1237 is a key amino acid residue that confers the higher inhibitory drugsensitivity to SUR1 (Ashfield et al., 1999; Hambrock et al., 2001; Hansen et al., 2002). The cryo-EM
structure of glibenclamide-bound KATP channels does show a close proximity of the drug to the S1237
residue, and also to Y230 (Martin et al., 2017). Mg2+-nucleotides seem to play an important role in the
sulfonylurea-mediated inhibition of KATP channels that contain SUR1; in inside-out excised-patches
sulfonylureas cause only a partial inhibition of the channel activity, but this inhibition at the same drug
concentration is markedly increased in the presence of Mg2+-nucleotides or in whole-cell configuration
(Gribble et al., 1997b; Gribble & Reimann, 2003). Contrastingly, SUR2-containing channels do not
exhibit any such drug-nucleotide allostery (Reimann et al., 2003). In addition to the well-established
clinical drugs such as sulfonylureas that act by direct binding to the SURs, KATP channel activity can
also be pharmacologically inhibited by potentially Kir6 subunit-specific inhibitors such as PNU37883A [PNU; Kir6.1>Kir6.2](Kovalev et al., 2004) and HMR1098 [HMR; Kir6.2>Kir6.1](Gögelein
et al., 2001; Zhang et al., 2010), whose specificity and mechanism are not well-studied.
A wide range of pharmacophores are known to activate KATP channels. Minoxidil, nicorandil,
pinacidil, and cromakalim are selective activators of SUR2-containing channels, while diazoxide is
more specific to SUR1 and SUR2B subunits (Giblin et al., 2002; Mannhold, 2004). Given the structural
diversity of potassium channel openers (KCOs), it is possible that there may be more than one
pharmacological opener binding site on SUR subunits. Based on the early chimeric studies using
KCOs (Uhde et al., 1999; Babenko et al., 2000; Moreau et al., 2000), the binding sites for sulfonylureas
and the KCOs may be distinct, with a hint of allostery between the two sites (Hambrock et al., 2001;
Löffler-Walz et al., 2002). Currently, there is no structural information regarding the KCO binding
site(s) of KATP channels.
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1.2

CS, NDM, and CHI — Congenital CV and pancreatic KATP
channelopathies

Given the ubiquitous nature and relative high density of their expression and the pivotal role that they
play in various physiological functions, it is unsurprising that any mutations (spontaneous or inherited)
involving the function/expression of KATP channels can cause channelopathies with very complex
pathophysiology.

1.2.1

Neonatal Diabetes and Congenital Hyperinsulinism

In pancreatic β-cells, the role of KATP channels is central to glucose-stimulated insulin secretion (GSIS)
(Ashcroft & Rorsman, 1990). Any alterations in the metabolic stimulus, KATP channel sensitivity to the
stimulus or the number of functional KATP channels in these cells can disrupt the coupling between
metabolism and electrical signalling, thereby altering the insulin secretion.
1.2.1.1

LOF Mutations in KCNJ11/ABCC8 – CHI

Congenital hyperinsulinism (CHI) is a rare genetic disorder characterized by dysregulated insulin
secretion (Aynsley-Green et al., 1981), and if left untreated, CHI causes severe hypoglycaemia, mental
retardation and epilepsy (Aynsley-Green, 1981; Meissner et al., 1997; Aynsley-Green et al., 2000; Menni
et al., 2001). It is now well-established that loss-of-function (LOF) mutations in the pancreatic β-cell
KATP channels are known to cause CHI and administering diazoxide, a specific activator of the
channels, is one of the main therapeutic interventions in managing CHI(Huopio et al., 2002).
More than 50 mutations throughout the Kir6.2/SUR1 gene-subunits cause CHI in humans
(Glaser et al., 1994; Aguilar-Bryan et al., 1995; Thomas et al., 1995a; Thomas et al., 1995b; Sharma et al.,
2000; Pinney et al., 2008). CHI mutations in the KATP channels can be broadly due to either functional
defects in expressed channels or trafficking defects that lead to reduced surface expression of channels.
Early studies of the functional consequences of CHI-associated G1479R mutation in the NBD2 of
the SUR1 subunit showed that it selectively abolishes MgADP-stimulation of KATP channel activity,
with no effect on ATP inhibition (Nichols et al., 1996). Several other missense mutations that cause
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MgADP insensitivity have been characterized (Shyng et al., 1998; Huopio et al., 2000). Albeit rare, nonsense mutations such as SUR1[Y12X] that cause large truncation of SUR1 or Kir6.2 proteins lead to
recessively inherited CHI (Thomas et al., 1996; Nestorowicz et al., 1997).
CHI mutations can lead to lack of functional channel expression as a result of transcriptional
or translational defects. In addition, altered trafficking mechanisms can be present. Sulfonylureas have
long been used to trigger insulin secretion and, as discussed above, cloning-expression studies have
confirmed that the target receptors for these drugs are KATP channels in the β-cells (Aguilar-Bryan et
al., 1995; Inagaki et al., 1995a). While functional KATP channels are octamers of Kir6/SUR subunits
(Shyng & Nichols, 1997), Kir6.2 tetramers can form functional ion-channels (Tucker et al., 1997).
However, each Kir6.2 subunit carries a characteristic Arg-Lys-Arg motif which acts as an endoplasmic
reticulum (ER) retention signal, that becomes occluded when complexed with the SUR subunit,
ensuring that only functional hetero-octamers are trafficked to the plasma membrane (Zerangue et al.,
1999).
1.2.1.2

GOF Mutations in KCNJ11/ABCC8 – NDM

In contrast to the LOF mutations in pancreatic β-cell KATP channels that cause CHI, gain-of-function
(GOF) mutations are predicted to decrease membrane excitability and thereby reduce GSIS. This
reduced insulin secretion would cause an increased glucose concentration in the blood, a phenotype
of diabetes mellitus. This hypothesis was confirmed originally using transgenic mice models that
express mutant KATP channels with decreased ATP-sensitivity (Koster et al., 2000). These mice showed
acute neonatal hyperglycaemia and decreased insulin secretion, predicting that such mutations should
also result in human diabetes (Koster & Nichols, 2002).
Neonatal diabetes mellitus (NDM) is a rare human condition, diagnosed early in life, with the
patients traditionally requiring regular insulin administration (Polak & Shield, 2004). Hyperglycaemia
in milder NDM cases (transient neonatal diabetes; TNDM) usually resolves within 18 months and
sometimes can persist longer causing permanent form of NDM (PNDM) (Stoffers et al., 1997;
Njolstad et al., 2001; Njølstad et al., 2003; Schwitzgebel et al., 2003). Genetic studies have now
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established that heterozygous GOF mutations in KCNJ11, encoding the Kir6.2 subunit, cause NDM
in humans, accounting for both PNDM (Edghill et al., 2004; Gloyn et al., 2004a; Gloyn et al., 2004b;
Vaxillaire et al., 2004; Massa et al., 2005) and TNDM (Gloyn et al., 2005; Yorifuji et al., 2005). PNDM
in extreme cases can be a much more severe disease involving overactivity of KATP in neurons, resulting
in additional neuronal complexities such as developmental delay and epilepsy in addition to the NDM
(Gloyn et al., 2004b; Vaxillaire et al., 2004; Massa et al., 2005).

1.2.2

Cantu Syndrome

Cantu syndrome (CS), first delineated in 1982(Cantu et al., 1982) is characterized by multiple
cardiovascular features, including enlarged heard, patent ductus arteriosus (PDA), pericardial effusion,
pulmonary hypertension, vascular dilation and tortuosity, lymphedema, coarse facial features, and
skeletal (Garcia-Cruz et al.; Rosser et al., 1998; Robertson et al., 1999; Concolino et al., 2000; Lazalde et
al., 2000; Engels et al., 2002; Grange et al., 2006; Kobayashi et al.; Garcia-Cruz et al., 2011; Scurr et al.;
Nichols et al., 2013). KATP channel opener (KCO) drugs such as diazoxide and minoxidil that have
been used historically to treat CHI and refractory hypertension, as well as a topical hair growth
promotion (in the case of minoxidil) are known to cause side effects that include excessive hair growth,
pericardial effusions, coarsening facial features, and edema in treated patients (Mehta et al., 1975;
Pennisi et al., 1977; Meisheri et al., 1988; Miki & Seino, 2005). The striking resemblance of these side
effects to CS features raised the hypothesis that CS might be the result of a K+ channel hyperactivity
(Grange et al., 2006). Additional studies described CS patients lacking mutations in ABCC9 but
carrying mutations in the KCNJ8 gene (Brownstein et al., 2013; Cooper et al., 2014). The demonstration
that both ABCC9 and KCNJ8 mutations encode gain-of-function in subsequent recombinant KATP
channels (Harakalova et al., 2012; van Bon et al., 2012; Brownstein et al., 2013; Cooper et al., 2014;
Cooper et al., 2017; McClenaghan et al., 2018) confirms the hypothesis that, despite the complex
pathophysiology, CS results from gain-of-function (GOF) mutations in the SUR2/Kir6.1 subunits of
muscle KATP channels.
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There is currently no treatment for this condition. Studies from the Nichols and Grange
groups have shown some evidence that sulfonylureas can be effective inhibitors of the mutant
channels (McClenaghan et al., 2020c) and may be beneficial in patients (Ma et al., 2019), but crossreactivity with pancreatic KATP channels, leading to hypoglycaemia remains a concern.

1.3

Zebrafish as Disease Models

As discussed below (in Chapter 5), genetically modified mouse models have given further insights to
the mechanisms underlying the pathophysiology of CS (Huang et al., 2018a; McClenaghan et al., 2018)
and therapeutic interventions (McClenaghan et al., 2020c), as well as to the pathological consequences
of Kir6.1/SUR2 LOF mutations. At the onset of this thesis project, however, the prospect of using
zebrafish as a novel experimental model for studying KATP was particularly appealing, given the
possibilities for much more rapid development and manipulation, and ultimately higher throughout
analysis of disease consequences and potential therapies. Zebrafish (ZF; Danio rerio) are small
freshwater teleost fish with a fully sequenced genome and in the past decade have emerged as a leading
animal model for various physiological studies (Lieschke & Currie, 2007; Howe et al., 2013; Hodgson
et al., 2018). ZF offer many distinct advantages – their highly conserved amenable genome and
electrophysiological similarity (Nemtsas et al., 2010; Vornanen & Hassinen, 2016; Emfinger et al., 2017;
van Opbergen et al., 2018b; Singareddy et al.) makes them potentially ideal to study congenital
cardiovascular and pancreatic diseases; their rapid development and fecundity (Hodgson et al., 2018)
facilitates high-throughput drug screening assays; their nearly transparent larvae that survive at high
ischemic conditions for up to 5 days-post-fertilization (dpf) (Poss, 2007) are well suited for imaging
studies.

1.3.1

Zebrafish Models of CS, NDM and CHI

Over the past 10 years, several efforts have been made towards developing transgenic and knock-in
ZF models (Sivasubbu et al., 2007; Prykhozhij & Berman, 2018). With significant advances in the
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CRISPR/Cas9 engineering that guarantee efficiency and affordability in mutagenesis, it has become
relatively simple to introduce human patient-specific GOF/LOF mutations into the equivalent ZF
genome (Jinek et al., 2012; Hruscha et al., 2013; Ranawakage et al., 2020; Choi et al., 2021; de Vrieze et
al., 2021).
KATP genes are not present below the vertebrates, and because of the genome duplication that
occurred in the teleost lineage, several human genes have at least two orthologues in ZF genome
(Howe et al., 2013; Glasauer & Neuhauss, 2014). Thus, although the fully sequenced genome of ZF
presents orthologs for almost all the human genes (Howe et al., 2013), including all the mammalian
KATP channel subunit genes – abcc8/kcnj11 and abcc9/kcnj8 (on chromosomes 25 and 4, respectively),
the Kir6 subunit gene has undergone such a duplication in ZF genome and as a result, ZF contain an
additional Kir6.3 subunit, encoded by kcnj11l gene (on chromosome 25) (Zhang et al., 2006).
1.3.1.1

LOF/GOF Mutations in kcnj11/abcc8 – ZF Models of CHI/NDM

Prior to the studies discussed later in this thesis, the tissue-specific characterization of zebrafish KATP
channels had only been performed in the pancreas. Emfinger et al. showed that the zebrafish pancreatic
β-cells express functional KATP channels with properties similar to that of mammalian KATP channels
containing Kir6.2/SUR1 subunits (Emfinger et al., 2017), with no evidence of Kir6.1, or the duplicated
ortholog Kir6.3 subunit expression. Mutations at residue R201 in Kir6.2 are the most common
KCNJ11 mutations underlying human NDM, most often resulting in a permanent condition, but
occasionally transient condition (Klupa et al., 2005; Koster et al., 2005; Gloyn et al., 2006; Lin et al.,
2006; Tarasov et al., 2006). Using CRISPR/Cas9 engineering, the Kir6.2[R201H] mutation was
introduced into the equivalent zebrafish locus, and the consequences are considered in Chapter 4.
Mutations that result in a loss of functional KATP protein in the β-cells are a prominent cause of CHI.
To model the loss of functional protein, an ABCC8 mutant ZF line (generated by ENU mutagenesis
from the Zebrafish Mutation Project (Kettleborough et al., 2013), containing an early frameshift
mutation in exon 10 of SUR1 (K499fs) was selected. This truncation disrupts transmembrane domain
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1, and the resultant fish, expected to have a loss of functional SUR1 protein, are also examined in the
Chapter 4.
1.3.1.2

GOF Mutations in kcnj8/abcc9 – ZF Models of CS

Prior to the commencement of the studies in this thesis, zebrafish knock-in lines (Cantú ZF) had also
been generated using CRISPR/Cas9, carrying CS patient-specific point mutations in the native
ABCC9 and KCNJ8 genes, resulting in amino acid substitutions equivalent to human SUR2[C1043Y],
SUR2[G989E] and Kir6.1[V65M] (Tessadori et al., 2018). These fish recapitulate key CV phenotypes
of CS, such as enlarged ventricles, enhanced cardiac output, and contractile function, and cerebral
vasodilation (Tessadori et al., 2018), and are examined at a molecular level in the Chapter 3.

1.4

Thesis Goals

The above sections have discussed prior studies of the composition, structure and function of ATPsensitive potassium (KATP) channels in mammalian tissues and studies determining the molecular basis
of the human disease pathologies that result from LOF or GOF mutations in these channels. They
have also highlighted the fact that the available pharmacology to treat such diseases is limited, primarily
by cross-reactivity between channel sub-types. Better understanding of the tissue specificity of
expression, the exact mechanisms linking the molecular dysfunction to the development of complex
pathophysiology, the potential for reducing cross-reactivity of drugs, and ultimately more specific
drugs, are needed. Many genetically modified mice have been used to model these diseases (Tinker et
al., 2018), with some success at explaining disease features (Pearson et al., 1999; Lopatin et al., 2000;
Koster et al., 2001; Nerbonne et al., 2001; Koster et al., 2002; Rajashree et al., 2002; Flagg et al., 2004;
Remedi et al., 2004; Dobrzynski et al., 2005; Dobrzynski et al., 2006; Remedi et al., 2006; Flagg et al.,
2007; Flagg et al., 2009; Remedi & Nichols, 2009a; Remedi & Nichols, 2009b; Schaeffer et al., 2009;
Glukhov et al.; Davis et al., 2020), but have received less attention as models for therapeutic drug
testing (Remedi & Nichols, 2008; McClenaghan et al., 2020c).
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As discussed above, ZF provide a potentially more viable and higher throughput model system
to carry out such studies, but, in comparison to mice, there have been very few studies of the
underlying molecular players in general, and of KATP channels in particular. The initial goal of this
thesis was therefore to develop methods to study the previously unaddressed molecular basis and
properties of KATP channels in ZF cardiovascular tissues, and the molecular consequences of
introduction of disease mutations. As the study progressed, additional revelations and complications
led to a broader study of the basis of KATP channels in the zebrafish cardiovascular system, and the
consequences of manipulation of KATP channel activity in cardiac and β-cells.
The following chapters therefore address detailed methods of isolation of ZF atrial, ventricular
and vascular smooth muscle myocytes for patch-clamp analysis (Ch. 2 (Singareddy et al.)) and the
molecular make-up of KATP in these tissues (Ch.3 (Singareddy et al., 2021b)), as well as unpublished
studies of the consequences of introduction of KATP disease mutations on channel activity and
expression, in cardiovascular tissues and pancreatic β-cells (Ch. 4).
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Figure 1.1 Mammalian KATP Channel Structure and Composition
(Left) Illustrations of hetero-octameric protein complex of the KATP channel, showing Kir6 tetramer surrounded by 4 SUR
subunits, indicating the two nucleotide binding domains (NBD1 and NBD2) of SUR, and a cross-section of the structural
model of the complex showing the ATP and MgATP binding sites. (Right) Composition of KATP in mammalian tissues.
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Chapter 2
Isolation of ZF Cardiovascular Myocytes
Zebrafish are small teleost fish that have long been used as a model vertebrate organism(Vascotto et
al., 1997) and have recently come to prominence as a viable vertebrate system for high throughput
screening for genes and drugs (Love et al., 2004; Keßler et al., 2015). However, physiological analysis
of zebrafish tissues is not well developed. In the cardiovascular system, methods have been described
for dissection of zebrafish hearts (Singleman & Holtzman, 2011) and isolation of ventricular cardiac
myocytes(Brette et al., 2008; Nemtsas et al., 2010; Sander et al., 2013). There are few detailed
descriptions of the effective isolation of atrial myocytes and no reports of vascular smooth muscle
(VSM) cell preparation for patch-clamp studies.
The current work describes modifications of previously reported protocols for zebrafish
ventricular myocyte isolation (Brette et al., 2008; Sander et al., 2013) and adaptations of methods from
mammalian VSM cell isolations (Huang et al., 2018a), allowing for the isolation of zebrafish VSM cells
from the bulbous arteriosus (BA). The protocols result in efficient yields of isolated atrial, ventricular,
and VSM cells from zebrafish that can be reliably used in patch-clamp studies for up to 8 h (Singareddy
et al., 2021b). Despite their nearly transparent larvae that develop entirely outside the parental
organism, study of cardiovascular development in ZF has been limited by challenges in extracting and
analyzing the tissues at a younger age. We addressed this limitation by adapting a published extraction
method(Burns & MacRae, 2006) and demonstrating patch-clamp experiments on zebrafish hearts
isolated as early as 3 days post-fertilization (dpf).
The work described in this chapter is currently in press at Journal of Visualized Experiments
(Singareddy et al.). SS developed the isolation methods and carried out essentially all of the
experiments, except as noted in Figure 2.3.
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1. Isolation of atrium, ventricle, and bulbous arteriosus from adult, juvenile, and larval
zebrafish
1.1. Euthanize fish using cold-shock, i.e., by immersing in 4 °C water, for ~10 s.
1.2. Using curved forceps, transfer fish into a large Petri dish partially filled with Perfusion Buffer
(PB) (Table 2.1) and place under a dissecting microscope.
1.2.1. Decapitate the fish just posterior to the eyes, using a pair of scissors.
1.3. Using curved forceps (fine forceps for larval fish), hold the fish in the non-dominant hand
with the ventral side facing the dissection scope. With the second pair of fine forceps (or
superfine for larval fish) in the dominant hand, gently tear open the pectoral muscles and fins
to reveal the cardiovascular (CV) tissues (atrium, ventricle, and bulbous arteriosus, BA)
(Figure 2.1).
1.4. Placing the fine forceps in the dominant hand, gently pull the BA at the intersecting tip of the
BA and the ventral aorta. The BA and heart will come out of the body cavity.
1.4.1. Carefully separate the BA from the aorta by pinching the forceps and locating the
atrium's tip into which multiple venous branches converge (sinus venosus). Using the
fine forceps, 'pluck' the tip of the atrium off the sinus venosus. This isolates the CV
tissues from the rest of the body (Figure 2.1).
2. Dissociation of cardiomyocytes from adult, juvenile, and larval zebrafish for
electrophysiological studies
2.1. Using the fine forceps, 'pluck' the atrium and ventricle out of the CV tissue isolated in the
earlier step. The process allows for clean dissection of each tissue with minimal crosscontamination and feels akin to plucking fruit from a tree.
2.1.1. Make a gentle tear into the ventricle using fine forceps to drain excess blood, which can
be ensured when the cardiac tissue turns pale salmon color from bright red.
2.2. Pool the isolated atrium and ventricle into separate 1.5 mL centrifuge tubes containing
Perfusion Buffer (PB; 1.5 mL). To guarantee successful dissociation of adult zebrafish atrial
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cardiomyocytes (ACMs) and ventricular cardiomyocytes (VCMs), typically four atria and three
ventricles are needed. In the case of juvenile zebrafish (28-90 days), this number is doubled.
2.2.1. In the case of larval zebrafish (14–28 days), collect as much tissue as possible from ~30
larvae.
2.3. Replace the PB in the tubes with 750 μL of Digestion Buffer (DB) (Table 2.1) each and place
the tubes on a thermoshaker at 37 °C and 800 rpm. Allow digestion of the tissues until they
become translucent (~30 min for the atria and ~40 min for the ventricles).
2.4. End the digestion by gently spinning down the tissues in a benchtop mini centrifuge (2,000 x
g at ambient temperature) for 3-5 s and replace the supernatant DB with 750 μL of Stopping
Buffer (SB) each (Table 2.1). This centrifugation step is optional for VCM isolation.
2.5. Incubate the pelleted tissues in the SB at ambient temperature for 15 min.
2.6. Gently replace the SB with 500-750 μL of PB each (depending on the desired density of the
final cells) and triturate the tissues (~30 times) using a flame-polished Pasteur pipette to
disperse the cells. The cardiomyocytes (CMs) are now ready for electrophysiological studies
and stored at room temperature for up to 8 h.
2.7. For uniform sampling, gently pipette the cells up and down a couple of times to resuspend
before adding a drop of them for corresponding studies.
3. Dissociation of vascular smooth muscle (VSM) cells from adult and juvenile zebrafish for
electrophysiological studies
3.1. Pluck bulbous arteriosus (BA) from the CV tissues using the same approach as step 2.1 and
pool five adult BAs into a 1.5 mL centrifuge tube containing S1 buffer (1.5 mL) (Table 2.1).
In the case of juvenile zebrafish, pool ten BAs and for larvae older than 2 weeks, pool 30-40
BAs. It is not practically feasible to isolate VSM cells from zebrafish larvae younger than 2
weeks.
3.2. Replace S1 with 400 μL of S2 buffer (Table 2.1) and allow papain digestion of the BAs on a
thermoshaker at 37 °C and 800 rpm for ~20 min.
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3.3. Allow the partially digested BAs to settle down for 1 min and replace the supernatant S2 with
500 μL of S3 buffer (Table 2.2) containing collagenase. Digest the tissues on a thermoshaker
at 37 °C and 800 rpm for 3-5 min.
3.4. End the digestion by gently spinning down the tissues in a benchtop mini centrifuge (2,000 x
g at ambient temperature) for 3-5 s and replacing supernatant S3 with 500 μL of S1.
3.5. Gently triturate the pelleted tissues (~15 times) to disperse VSM cells and plate onto glass
coverslips of appropriate size. The coverslip size is determined by the size of the patch-clamp
recording chamber, in this case, 5 x 5 mm was used).
3.5.1. Keep the coverslips at room temperature for 30 min for the cells to attach and use them
within the next 6 h.
4. Isolation of hearts from embryonic zebrafish for electrophysiological studies
4.1. Add tricaine (150 mg/L; 1 ml per 100 mm x 20 mm Petri dish) to ~300 embryos (2-5 dpf),
collected from their incubated condition (Figure 2.2A).
4.1.1. Concentrate the anesthetized embryos by transferring them to a 5 mL centrifuge tube
using a transfer pipette, removing excess media (E3) from the centrifuge tube (Figure
2.2B).
4.2. Wash the embryos with 3 mL of cold Perfusion Buffer (PB) twice and resuspend in 2 mL of
PB (Figure 2.2B).
4.3. Using the embryonic heart isolation apparatus (Figure 2.2C), use the syringe to draw ~1 mL
of the embryos into the needle and immediately expel them back into the tube. Repeat this
process 30 times, at a rate of 1 s per syringe motion (Figure 2.2C).
4.4. Pass the fragmented embryos through a 100 μm cell-strainer sieve placed in a funnel and
collect the filtered hearts in another 5 mL centrifuge tube. Rinse the syringe with 1 mL of PB
and collect this rinse as well into the tube through the sieve (Figure 2.2C).
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4.5. Mix well and separate into 1.5 mL centrifuge tubes, with each tube containing 1 mL of the
contents. Centrifuge all the tubes on a benchtop mini centrifuge for 5 s (2,000 x g at ambient
temperature) and discard the supernatants.
4.6. Carry out serial resuspension of the pellets in the tubes using 1 mL of PB, i.e., resuspend the
pellet in one tube using 1 mL of PB and use that resuspended PB to resuspend the pellet in
the next tube.
4.7. Gently pipette the hearts up and down two times before adding a drop of them for
corresponding studies.
5. Patch-clamp studies on isolated cardiovascular cells
Inside-out and whole-cell patch-clamp recordings from the isolated cells can be obtained as previously
reported for KATP channel currents in zebrafish cardiovasculature (Singareddy et al., 2021b).
5.1. For adult and juvenile cardiomyocytes, add the dissociated cells (from step 2) directly to the
recording chamber from suspension. For VSM cells, place the coverslip containing the plated
VSM cells (from step 3) into the recording chamber.
5.2. Add isolated intact embryonic hearts (from step 4) to the chamber from suspension, and
make patch-clamp recordings from the epicardial myocytes (Figure 2.2D).
REPRESENTATIVE RESULTS:
The above protocols reliably and routinely provide sufficient cardiac and vascular myocytes of
consistent quality for patch-clamp studies as recently reported in extensive studies of ATP-sensitive
potassium (KATP) channels in wild-type and mutant zebrafish cardiovasculature in the Chapter 3
(Singareddy et al., 2021b). Representative traces of recordings of such KATP channel activity from
isolated cardiomyocytes are shown in Figure 2.3A-C. In the case of cells isolated from bulbous
arteriosus, the vascular smooth muscle cells were confirmed by Tg(tagln:egfp) expression(Yang et al.,
2003; Seiler et al., 2010) (Figure 2.1). Successful single-channel recordings were obtained (n = 8
recordings from N = 5 preparations) in patches excised from the embryonic hearts (Figure 2.3D).
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Action potentials were recorded from isolated adult zebrafish ventricular and atrial myocytes in wholecell, current-clamp mode, using a patch-clamp amplifier along with a compatible digitizer. The
extracellular recording solution for the action potential (AP) measurements contained NaCl (140 mM),
KCl (4 mM), CaCl2 (1.8 mM), MgCl2 (1 mM), Glucose (10 mM), HEPES (10 mM), and Blebbistatin
(0.01 mM, pH 7.4); the intracellular recording solution contained KCl (120 mM), EGTA (5 mM),
K2ATP (5 mM), MgCl2 (5 mM), and HEPES (10 mM, pH 7.2). Patch pipettes were pulled from sodalime glass and had resistances of 3 – 5 MΩ when filled with intracellular solution. Ventricular myocytes
exhibit stable hyperpolarized membrane potentials, and action potentials were stimulated via current
injection through the patch pipette (Figure 2.3E), whereas atrial myocytes exhibited spontaneous
action potential firing (Figure 2.3F). Action potential properties are summarized in Table 2.3.
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Figure 2.1 Isolation of ZF Atrial, Ventricular and VSM Cells
Schematic to illustrate the isolation of atrial (A), ventricular (B), and bulbous arteriosus (C) cells. The images depict each
isolated cell type (bottom) have scale bars = 50 µm in each case. BA cells isolated from smooth muscle cell transgenic
reporter zebrafish lines (Tg(tagln:egfp) (Yang et al., 2003; Seiler et al., 2010)) are positive for green fluorescence.
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Figure 2.2 Isolation of Embryonic ZF Hearts
(A) Fertilized embryos are removed from the breeding tank and placed in a Petri dish containing E3 water and maintained
at 28 °C for up to 5 days. (B) At desired age, embryos are anesthetized in situ using tricaine and transferred into PB in 5
mL centrifuge tubes for dissociation. (C) Embryonic heart isolation apparatus consists of a 10 mL syringe attached to a
19 G needle mounted above the dissociation tube on a bench stand, allowing the hands to perform the trituration. (D)
Image of the isolated heart (day 4) attached to a patch-clamp pipette.
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Figure 2.3 Ion Channel Recordings from Isolated ZF Cardiovascular Myocytes
(A, B) ATP-sensitive KATP channels from inside-out excised patch-clamp recordings of atrial (A) and ventricular (B)
cardiomyocytes isolated from adult zebrafish. (C) KATP channel conductance was recorded from whole-cell patch-clamping
of VSM cells isolated from adult zebrafish. (D) Single K+ channel activity in membrane patches excised from zebrafish
embryonic hearts (4 dpf). All excised patch recordings were made with 140 mM KCl on both sides of the membrane, at 50 mV membrane potential. Whole-cell currents were recorded with the membrane potential clamped at -70 mV. (E)
Example current-clamp recording from the isolated ventricular myocyte. Action potentials were stimulated by current
injection as shown, for example, at the bottom. (F) Example current-clamp recording from isolated atrial myocyte showing
spontaneous action potential firing.
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10 mM HEPES, 30 mM Taurine, 5.5 mM Glucose, 10 mM BDM. Make the
Perfusion Buffer (PB)

solution in phosphate-buffered saline (PBS), adjust pH to 7.4

Digestion Buffer (DB)

PB + 12.5 µM CaCl2 + 5mg/ml Col II + 5mg/ml Col IV + 5 ng/ml Insulin

Stopping Buffer (SB)

PB + 10% FBS + 12.5 µM CaCl2 + 10 mg/ml BSA + 5 ng/ml Insulin
Table 2.1 Solutions for Isolation of ZF Cardiomyocytes

S1 Buffer

0.1% BSA (w/v), 145 mM NaCl, 4 mM KCl, 10 mM HEPES, 10 mM
Glucose, 0.05 mM CaCl2, 1 mM MgCl2, adjusted to pH 7.4 using NaOH

S2 Buffer

2 ml S1, 4 mg Papain, 2 mg DTT

S3 Buffer

2 ml S1, 3 mg Collagenase Type H, 2 mg Trypsin Inhibitor, 1 mg Elastase
Table 2.2 Solutions for Isolation of ZF VSM Cells
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Ventricular Myocytes (n = 3 Recordings)
Vm (mV)

APA (mV)

APD50 (ms)

-75.7 ± 3.9

-119.6 ± 3.8

329 ± 163

Atrial Myocytes (n = 3 Recordings)
AP Rate (min-1)

MDP (mV)

APA (mV)

APD50 (ms)

107.3 ± 32.6

-71.2 ± 5.1

98.4 ± 4.7

141 ± 12

Table 2.3 Action Potential Properties from Isolated ZF Cardiomyocytes
Recorded in current clamp mode. Data shown as mean ± S.D. Vm = membrane potential; APA = action potential
amplitude; APD50 = duration of action potential to 50% repolarization; MDP = maximal diastolic potential.

28

Chapter 3
KATP Channels in Zebrafish Cardiovasculature
Mammalian KATP channels are hetero-octameric potassium-selective ion channels composed of 4
pore-forming inwardly rectifying Kir6.x subunits (Kir6.1 or Kir6.2 encoded by KCNJ8 and KCNJ11,
respectively) and 4 regulatory sulfonylurea receptor SURx subunits (subfamily C: SUR1, SUR2
encoded by ABCC8 and ABCC9), whose molecular heterogeneity is further increased by variable
splicing of SUR2 into at least two distinct isoforms: SUR2A and SUR2B (Nichols, 2006b). KATP
channels in different tissues exhibit distinct nucleotide sensitivities as a result of distinct subunit
compositions. In mammals, Kir6.2 is coupled with SUR1 in the pancreas and in neurons, Kir6.2 is
coupled with SUR2A in striated muscles, and Kir6.1 is coupled with SUR2B in VSM. The discovery
of gain-of-function (GOF) or loss-of-function (LOF) mutations in KCNJ8 and ABCC9 as causes of
Cantú Syndrome (CS) (Harakalova et al., 2012; van Bon et al., 2012; Brownstein et al., 2013; Cooper et
al., 2014; Cooper et al., 2017; McClenaghan et al., 2018) or ABCC9-related Intellectual disability and
Myopathy Syndrome (AIMS) (Smeland et al., 2019), respectively, provides a clear illustration of the
pathologic potential of KATP channels.
Several studies suggest a close similarity between the electrical activity of ZF and human
cardiomyocytes (Nemtsas et al., 2010; Vornanen & Hassinen, 2016; van Opbergen et al., 2018a), but
electrophysiological studies of fish vascular myocytes in general are lacking, and there has been no
molecular dissection of fish cardiovascular KATP channels. Because of the early genome duplication
that occurred in the teleost lineage (Vornanen & Hassinen, 2016), ZF contain at least two orthologues
for many human genes, including a novel KATP subunit – Kir6.3 (encoded by kcnj11l) (Zhang et al.,
2006), and there could be significant differences between the molecular basis of KATP in ZF and human
CV system (Hassinen et al., 2015).
In this study, a comprehensive combination of genetically modified fish, electrophysiology,
and gene expression analysis, was used to demonstrate that ZF cardiac and vascular smooth muscles
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express functional KATP channels of similar subunit composition, structure, and metabolic sensitivity
to their mammalian counterparts, validating the use of genetically modified ZF KATP to model human
CV KATP channelopathies.
The work described in this chapter is published in Journal of Physiology (Singareddy et al.,
2021b). SS carried out all the experiments, except the RT-PCR study shown in Figure 3.1.

3.1

Zebrafish cardiac and vascular muscle express multiple KATP
subunit transcripts

PCR was performed on cDNA generated from RNA isolated from the zebrafish CV system, to
characterize Kir6 and SUR subunit expression in the zebrafish cardiac ventricle and atrium, and from
the bulbous arteriosus (Figure 3.1A). SUR2A, SUR2B (abcc9), Kir6.1 (kcnj8) and Kir6.2 (kcnj11), were
detected but not SUR1 (abcc8) or Kir6.3 (kcnj11l) (Figure 3.1B). Notably, only Kir6.1 and SUR2B were
detected in the bulbous arteriosus (Figure 3.1C), which consists primarily of vascular smooth muscle
cells (VSMCs), consistent with Kir6.1/SUR2B complexes forming vascular smooth muscle KATP
channels, as in mammals. The additional presence of Kir6.2 and SUR2A expression in the heart
(Figure 3.1C) is consistent with cardiomyocyte KATP being formed of these subunits as in mammals,
but the heart is innervated and permeated by capillaries, and hence the presence of Kir6.1 and SUR2B
transcripts in ventricle and atrium may reflect the presence of these other cell types.

3.2

Zebrafish cardiac muscle myocytes express functional KATP
channels

As shown in Figure 3.2A, both ventricular and atrial myocytes express robust ATP-sensitive potassium
currents, with similar sensitivity to ATP in the absence or presence of Mg2+ (Figure 3.2B), but at
slightly higher density and lower sensitivity in the atrium (Figure 3.2B). Similar to mammalian KATP
channels, ADP in the presence of Mg2+ markedly activated atrial and ventricular KATP to a similar
extent (Figure 3.2C). As shown by ion replacement of K+ by Na+ (Figure 3.3), the channels are highly
K+-selective in both the atrium and ventricle, with single-channel conductance of ~80pS in 140 mM
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KCl on either side of the membrane (Figure 3.3), essentially the same as seen in mammalian myocytes
(Babenko et al., 1998b).

3.3

Ventricular and atrial KATP channels are generated by Kir6.2
and SUR2 subunits

To define the subunit composition of the functional KATP channels in each of the different tissues,
currents were characterized from multiple genetically modified fish. Both atrial and ventricular KATP
currents were indistinguishable from control, both in terms of ATP sensitivity in SUR1 and Kir6.1
knockouts, although the density was slightly lower in SUR1 knockouts, but currents were abolished
in SUR2 and Kir6.2 knockouts (Figure 3.4A-C, 5A-C). These data confirm that SUR2 and Kir6.2 are
essential components of functional KATP channels in both chambers, and that neither SUR1 nor Kir6.1
contribute significantly. SUR2[G898E], SUR2[C1043Y] and Kir6.1[V65M] mutations are associated
with CS (Grange et al., 2019), and have been shown to cause GOF in recombinant channels (Cooper
et al., 2015; Cooper et al., 2017; McClenaghan et al., 2018). Strikingly and essentially confirming the
contribution of SUR2 but not Kir6.1 to active cardiac channels, ATP sensitivity was also markedly
reduced in patches from SUR2[G898E] and SUR2[C1043Y], but not Kir6.1[V65M], myocytes from
both ventricle (Figure 3.4B, D) and atrium (Figure 3.5B, D).

3.4

Vascular smooth muscle KATP channels are generated by Kir6.1
and SUR2 subunits

KATP channels were not detected in excised membrane patches from bulbous arteriosus (BA). In
whole-cell voltage clamp recordings, measurable K conductance was present with zero ATP in the
pipette but absent when 100 μM ATP was included, similar to what is seen in mammalian vascular
smooth muscle (Figure 3.6A)(Li et al., 2013; Huang et al., 2018b). In marked contrast to cardiac
myocytes, KATP currents were absent in Kir6.1 knockout vascular smooth muscle myocytes (Figure
3.6B). In addition, ATP-sensitive K+ conductance was markedly increased in vascular smooth muscle
myocytes from heterozygous Cantú SUR2[G898E] and Kir6.1[V65M] (Figure 3.6B), and dramatically
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so in homozygous Kir6.1[V65M] (Figure 3.6B) further confirming that VSM KATP channels are formed
of SUR2 and Kir6.1 subunits, as in mammalian smooth muscle (Huang et al., 2018b).

3.5

Zebrafish cardiac and vascular smooth muscle KATP channels
are insensitive to K+ channel openers

Mammalian KATP channels are activated by a wide range of chemical potassium channel openers
(KCOs), including pinacidil, minoxidil, and diazoxide (Flagg et al., 2010). There are indirect indications
that fish KATP channels may lack KCO sensitivity (Paajanen et al., 2002), but this has not been studied
directly. As shown in Figure 3.7A, zebrafish cardiac myocytes in both atrium and ventricle show no
response to 100 μM of pinacidil or minoxidil, under conditions that cause marked activation of mouse
cardiac KATP channels. Although diazoxide causes activation of SUR1-containing KATP channels from
zebrafish pancreatic b-cells (Figure 3.7A), diazoxide also has no effect on cardiac KATP, arguing that
SUR1 is not a significant component of the latter. Furthermore, while pinacidil causes marked
activation of whole-cell KATP currents in mouse vascular smooth muscle myocytes, again there is no
activation of zebrafish bulbous arteriosus channels (Figure 3.7C).
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Figure 3.1 Zebrafish Cardiovascular Cell Types and KATP Channel Subunit Expression
(A) Photomicrograph (left) of isolated zebrafish heart (green filter lens) reveals atrium (A), ventricle (V) and bulbous
arteriosus (BA). Scale bar 1 mm. Images of isolated cells (right) from each tissue. BA cells expressing GFP are shown under
UV illumination. Scale bars 100 µm. (B) RT-PCR analysis of KATP channel subunit expression, including SUR2a and
SUR2b isoforms, and gapdh. (C) Quantification of data from B.
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Figure 3.2 KATP Channel Current in Ventricular and Atrial Myocytes
(A) Representative inside-out patch-clamp recordings from ventricular (VCM, above) and atrial (ACM, below) cardiac
myocytes in the presence of differing [ATP], with (right) or without (left) Mg2+ ions. (B) [ATP]-dependence of channel
activity (Irel) for VCM and ACM, from recordings as in A (n=3-7 recordings from n=3 preps (3 animals per prep) in each
case). (above) Dose-response relationships were fit with Hill plots (Eqn. 1). Graph shows fit to averaged data, inset shows
individual data, mean and s.d. for fits to individual recordings. (below) Measured KATP density (current in zero ATP). (C)
(left) Representative inside-out patch-clamp recordings from VCM and ACM, in the presence of differing [ATP] and
[ADP], with Mg2+ ions. (D) Currents in 0.1 mM ATP, with or without ADP, relative to current in zero ATP (Irel). Graph
shows individual data, mean and s.d.
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Figure 3.3 Single Channel KATP Currents in Ventricular and Atrial Myocytes
(A, B) (left) Representative inside-out current recordings from VCM (A) and ACM (B) in 140mM K on both sides of the
membrane and after replacement of cytoplasmic solution with 4 mM K/136 mM Na. Markers indicate zero current (right)
Single channel I-V relationships from each condition.
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Figure 3.4 Subunit Dependence of KATP Channels in Ventricular Myocytes
(A, B) Representative inside-out patch-clamp recordings from VCM in the presence of differing [ATP], as in Figure 2A,
from KATP subunit knockout fish (A), and Cantú mutant fish (B). with (right) or without (left) Mg2+ ions. (C) Measured
KATP density (current in zero ATP) from individual experiments as in A,B (n= 3-24 recordings from 1-3 preps (3 animals
per prep), in each case). (D) [ATP]-dependence of channel activity (Irel) from recordings as in A,B. (above) Dose-response
relationships were fit with Hill plots (Eqn. 1). Graph shows fit to averaged data, inset shows individual data, mean and s.d.
for fits to individual recordings.
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Figure 3.5 Subunit Dependence of KATP Channels in Atrial Myocytes
(A, B) Representative inside-out patch-clamp recordings from ACM in the presence of differing [ATP], as in Figure 2A,
from KATP subunit knockout fish (A), and Cantú mutant fish (B). with (right) or without (left) Mg2+ ions. (C) Measured
KATP density (current in zero ATP) from individual experiments as in A,B (n= 3-12 recordings, from 1-3 preps (4 animals
per prep), in each case). (D) [ATP]-dependence of channel activity (Irel) from recordings as in A,B. (above) Dose-response
relationships were fit with Hill plots (Eqn. 1). Graph shows fit to averaged data, inset shows individual data, mean and s.d.
for fits to individual recordings.
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Figure 3.6 Subunit Dependence of KATP Channels in Bulbous Arteriosus Myocytes
(A) (left) Representative whole-cell voltage-clamp recordings from WT BA smooth muscle myocytes with zero 0.1 mM
ATP in the recording pipette. Currents were recorded with 136 mM Na / 6 mM K (Na+) in the bath or 0 Na / 140 K
(K+) as indicated. (right) Measured K current density (current in K+ - current in Na+) from individual experiments as at left
(n = 4 recordings from 2 preps (5 animals per prep), in each case). (B) (left) Representative whole-cell voltage-clamp
recordings from Kir6.1 knockout and hetero- or homozygous Cantú mutant zebrafish as indicated. (right) Measured K
current density (current in K+ - current in Na+) from individual experiments as at left (n = 3-10 recordings from 1-3 preps
(5 animals per prep), in each case).
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Figure 3.7 K+ Channel Opener Insensitivity in Zebrafish Cardiovascular Myocytes
(A) (left) Representative inside-out patch-clamp recordings from zebrafish and mouse VCM, as indicated, in the presence
of differing [ATP], with or without pinacidil (0.1 mM, PIN) or minoxidil (0.1 mM MNX). (right) Currents in 0.1 mM ATP
with and without drug (Irel). Graph shows individual data, mean and s.d. (n = 3, in each case). (B) (left) Representative
inside-out patch-clamp recordings from zebrafish VCM and pancreatic -cell, as indicated, in the presence of differing
[ATP], with or without diazoxide (0.1 mM, DZX). (right) Currents in 0.1 mM ATP with and without DZX (Irel). Graph
shows individual data, mean and s.d. (n = 3 recordings from 1 prep each), in each case). (C) (left) Representative wholecell voltage-clamp recordings from zebrafish BA (VSM) and mouse aortic VSM, as indicated, with or without addition of
pinacidil (0.1 mM, PIN). (right) K current density in high K+ solution, with and without PIN. Graph shows individual data,
mean and s.d. (n = 3 recordings from 1 prep in each case).
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Chapter 4
Potassium Channel Remodeling in Pancreatic β-Cells
In both zebrafish (Emfinger et al., 2017) and mammalian pancreatic β-cells (Miki et al., 1999), KATP
channels are composed of Kir6.2 and SUR1. Although previous studies have not revealed any
significant remodeling of channel subunits, this chapter will describe experiments that explored
changes in the activity of KATP and other potassium channels, in response to genetic manipulation of
pancreatic KATP subunits.
Most of the work described in this chapter is unpublished, with the exception of data in Figure
4.4, which is pre-published (Ikle et al., 2021). SS carried out essentially all of the experiments, except
for the physiological data in Figures 4.3 and 4.4.

4.1

Reduced ATP-Sensitivity, Channel Density in Kir6.2[R201H]
Zebrafish

Several novel KATP constructs were introduced into the zebrafish genome, with a view to generating
gain- or loss-of function models of neonatal diabetes and congenital hyperinsulinism, respectively.
Initially, KATP channel properties were examined in pancreatic β-cells, isolated as per previously
established protocols (Emfinger et al., 2017) from zebrafish carrying the neonatal diabetes-associated
Kir6.2[R201H] mutation, knocked-in to the endogenous kcnj8 locus (generated at Vanderbilt
University by a collaborator, Dr Wenbiao Chen). Excised inside-out patch currents (Figure 4.1) reveal
the predicted reduction of ATP-sensitivity of these channels in heterozygous, and more so in
homozygous, conditions. As Kir6.2 is also the prominent channel-forming subunit in the heart
(Chapter 3), a loss of ATP-sensitivity was to be expected in ventricular myocyte KATP. As shown in
Figure. 4.2, this is indeed the case but, more strikingly, there is also a very clear reduction of channel
density in this case. Further analysis of channel density in the pancreatic β-cells reveals that at a similar
age (~3-4 months), there is a less pronounced, yet significant, reduction of KATP channel density.
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4.2

Kir6.2[R201H] Does Not Induce Permanent Diabetes in ZF

R201H is the most common human NDM-associated Kir6.2 mutation in humans, and has been
associated with both the transient (TNDM) and permanent (PNDM) forms of the syndrome (Klupa
et al., 2005; Koster et al., 2005; Gloyn et al., 2006; Lin et al., 2006; Tarasov et al., 2006). We tracked
blood sugar over time in ZF containing the homozygous R201H mutation (Figure 4.3). While these
fish are transiently hyperglycemic, glycemia remits to normal levels after approx. 12 weeks of age.
Moreover, the channel density in β-cells with R201H is lower than WT and trends to decrease with
increase in age (inversely correlating with the remitting glucose levels). The density of β-cells in the
primary islets is lower in homozygous R201H and coincides with a unique increase in the zebrafish
secondary islets (Figure 4.3), perhaps a compensatory mechanism. Initially, these fish thus appeared
to represent a potential important first animal model of TNDM (see Discussion). However, the fish
were initially generated with the concurrent presence of a H2B:RFP marker, which results in
expression of a red fluorescent protein in the β-cells. Outcrossing was later used to remove this
marker. Hyperglycemia was not observed in zebrafish when the H2B:RFP marker was removed,
despite the GOF from R201H still being evident at a molecular level.

4.3

Truncated SUR1 Abolishes KATP in ZF Pancreatic β-Cells

To explore the possibility of using zebrafish for modeling CHI, we also examined zebrafish in which
a SUR1-truncation mutation (K499X) was introduced into the abcc8 gene. Genome mutagenesis was
performed at the Sanger Institute, as part of the Zebrafish Mutation Project, using N-ethyl-Nnitrosourea (ENU), in an attempt to identify knockout alleles for all protein-coding regions in the
zebrafish genome (https://www.sanger.ac.uk/resources/zebrafish/zmp/). The project outcrosses
ENU-mutagenized F0 males to create a population of F1 fish heterozygous for ENU-induced
mutations, which are then obtained through the Zebrafish International Research Consortium
(ZIRC). An abcc8(sa15863) nonsense mutant allele (which we designate as SUR1-KO)

which

introduces a STOP codon immediately after the residue K499 was obtained from the Zebrafish
41

Mutation Project (Kettleborough et al., 2013), through the ZIRC. Homozygous SUR1-KO- were
generated by in-crossing heterozygous carriers. Inside-out excised patch-clamp analysis revealed a
complete absence of channel activity in β-cells from SUR1-KO (Figure 4.4). This result confirms an
absolute requirement for SUR1 in the generation of functional KATP channels in ZF β-cells. In contrast
to the initial prediction that this should lead to continuous insulin secretion and hypoglycemia, no
difference in random blood glucose was detected in heterozygous or homozygous SUR1-KO fish
(Figure 4.4), mimicking findings in SUR1-knockout mice. Mutant fish also demonstrated impaired
glucose tolerance, like LOF mouse models.

4.4

Reduced KATP in Mice Pancreatic β-Cells is Associated with
Up-Regulation of A Novel Large-Conductance K+ Channel

High glucose promotes dynamin-dependent endocytosis of KATP channels, and reduces levels of SUR1
protein in the membrane (Han et al., 2018). There is also evidence that KATP density is reduced in
mouse β-cells that have been chronically incubated in high glucose in vitro (Figure 4.5A) (Shyr et al.,
2019). Further exploratory studies of this phenomenon, carried out initially to assess the potential
consequences for β-cell excitability, revealed some previously unrecognized remodeling.
KATP channel activity was assessed in excised inside-out patches from mouse pancreatic β-cells,
which had been incubated in different glucose conditions. KATP channel density decreased as the
glucose concentration in which these islets were incubated increased (Figure 4.5A), confirming
previous observations made using whole-cell patch clamp measurements (Shyr et al., 2019).
Interestingly, reduction of KATP activity – whether in the case of incubation in high glucose, or from
genetic models of decreased KATP density – was associated in each case with other channels being upregulated (Figure 4.5B, C). As shown in Figure 4.5C, β-cells from SUR1-KO mice, completely lacking
KATP, as well as from Pdx-Cre induced AAA mice (which express a strong dominant-negative Kir6
construct that also leads to almost complete absence of KATP (Malester et al., 2007), as well as Pdx-Cre
induced Kir6.2-ΔN30,K185Q mice (which express a strong GOF mutation in β-cells, resulting in
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profound hyperglycemia (Remedi et al., 2009), but lowered KATP density), all showed these channels
(Figure 4.5) – but such channels were not seen in untreated WT β-cells (~100 excised patches).
These unidentified channels are K+-selective, with a single-channel conductance of ~240pS,
when measured in 140 mM [K+] on both sides of the membrane (Figure 4.6). Switching from 140 mM
KCl in the bath solution (with 140 mM KCl in the extracellular pipette solution) to 140 mM NaCl in
one of the bath lanes outside the pipette, current reversal shifted to positive voltages, confirming that
these are not Cl- channels, and are highly K+-selective (note that the Na+ and K+ concentrations are
reversed here in comparison to the normal physiological levels). Another feature that was consistently
observed is higher channel activity at hyperpolarized potentials than at depolarized potentials.
The high single-channel conductance is typical of members of the large-conductance Na+activated or Ca2+-activated K+-channel sub-family. Inactivating Ca2+-activated (BK) channels have
been well described in pancreatic β-cells (Lingle et al., 1996; Li et al., 1999), consistent with their
presence here – when β-cell membrane patches were exposed to stimulatory (133 μM) Ca2+ in the
bath, typically 3-10 channels of 300 pS, activated extremely quickly, but then rapidly inactivated (to a
Po <~0.05) within ~1s (Figure 4.7). These are the typical rapidly inactivating BK channels that are
reported to be present in the murine pancreatic β-cells (Li et al., 1999). They were present in both WT
and low-KATP β-cells, and clearly distinguishable from the up-regulated channels observed in the latter.
When present, the up-regulated ~240 pS channels were unaffected by the Ca2+ in the bath. In addition,
Paxilline, a pore-blocker of BK channels, that can block from either side of the membrane, also had
no effect on the up-regulated channels (at up to 350 μM) (Figure 4.7).

4.4.1

Similar Large-Conductance K+ Channels in Diabetic Human β-Cells

Preliminary experiments were also carried out to examine K+ channel properties in human pancreatic
β-cells. Dr Maria Remedi kindly provided isolated pancreatic β-cells from cadaver specimens.
Although further experiments are clearly needed, excised patch-clamp measurements from these cells
reveal several striking consistencies with the above data obtained in mouse β-cells. First, excised
human β-cell membrane patches from one diabetic and one non-diabetic pancreas reveal KATP
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channels with typical nucleotide sensitivity in both, but suggest that the diabetic β-cells have reduced
KATP expression (Figure 4.8).
Intriguingly, although not detected in the non-diabetic β-cells, unidentified ATP-insensitive
K+ channels of ~240 pS conductance were observed in 5 out of 20 patches from the diabetic human
β cells. Again, these are not BK, which are also readily detectable as inactivating Ca2+-sensitive
channels in these cells. Preliminary anecdotal observations suggest that human β-cells may have higher
BK density than in mouse, although KATP density may be lower (Figure 4.8). In addition, BK
inactivation may be less complete than in mouse, with a higher residual Po.
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Figure 4.1 Kir6.2[R201H] Causes GOF and Lower Channel Density in ZF Pancreatic β-Cells
(A, left) Representative inside-out patch-clamp recordings from wild type (WT, above), heterozygous R201H (wt/RH,
middle) and homozygous R201H (RH/RH, below) pancreatic β-cells without Mg2+ ions. (A, right) [ATP]-dependence of
channel activity (Irel) for each genotype, from recordings as at left (n=3-7 recordings from N=3 preps (3 animals per prep)
in each case). (B) KATP channel density is lower in R201H β-cells, and decreases as the glucose levels start to remit.
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Figure 4.2 Kir6.2[R201H] Causes GOF and Lower Channel Density in ZF Cardiomyocytes
(A) Representative inside-out patch-clamp recordings from wild type atria (WT,) heterozygous R201H (wt/RH) atria
(ACM) and ventricles (VCM) in the presence of Mg2+ ions. (B) [MgATP]-dependence of KATP channel activity (Irel) WT
and heterozygous R201H atria (n=3 recordings from N=1 preps (3 animals used)). (B) KATP channel density is lower in
heterozygous R201H atrial and ventricular myocytes compared to WT.
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Figure 4.3 Kir6.2[R201H] Causes Transient Diabetes in Zebrafish
(A) TNDM in R201H zebrafish. (B) R201H zebrafish lose β-cells in their primary islets and this coincides with an increase
in incidence of secondary islets across the pancreas.
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Figure 4.4 Zebrafish Models of CHI
(A) Schematic of SUR1 protein structure showing functional domains and predicted truncation resulting from premature
stop mutation (K4899X) within TMD1. (B) Body weight in WT (n=11), heterozygous SUR1+/- (n=12) and homozygous
SUR1-/- (n=12) fish at age 8 weeks. (C) Fasting blood glucose over time shows no significant difference between
homozygous mutants and controls (n=11-16 per timepoint). (D) Intraperitoneal GTT shows non-significantly impaired
response to glucose load in SUR1-/-, relative to WT or SUR1+/- fish (n=8-16 per timepoint). KATP channels in WT
zebrafish secondary islet β-cells show the presence of Kir6.1. (E) Representative KATP channel activity in inside-out patch
clamp recordings of WT (above) and homozygous SUR1[499X] (SUR1-/-) mutant β-cells (below). Voltage was clamped at
-50mV. (F) KATP channel density in WT and SUR1-/- patches (n=17,10).
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Figure 4.5 Loss of KATP – Upregulation of Large-Conductance Channels
(A) KATP channel density is reduced when mice pancreatic β-cells are incubated in high glucose conditions for 10 days,
with the amount of loss proportional to the concentration of glucose. (B, C) Loss of KATP channels is associated with
upregulation of unknown (D) ATP-insensitive large-conductance channels. Data based on inside-out excised patch clamp
recordings where n refers to the number of patches.

49

Figure 4.6 Upregulated Large-Conductance K+ Channels
The upregulated channels show a single-channel conductance of ~240 pS, possible sub-conductance states, selectivity to
K+ ions and higher activity at negative membrane potentials.
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Figure 4.7 Upregulated Large-Conductance K+ Channels are Distinct from BK Channels
(A) The mice pancreatic KATP β-cells show normal inactivating BK channels. (B) The upregulated large-conductance K+
channels are unaffected by 133 μM Ca2+ and (C) are insensitive to paxilline.
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Figure 4.8 KATP and Large-Conductance K+ Channels in Human Pancreatic β-Cells
(A) Human pancreatic β-cells express functional KATP channels, (B) but with a slightly reduced density in the diabetic
pancreas. (C, D) Diabetic human pancreatic β-cells show upregulated large-conductance Κ+ channels distinct from the
canonical BK channels.
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Chapter 5
Thesis Discussion
5.1

Isolation of Single Cells from ZF Cardiovasculature

Previous methods for isolating ventricular myocytes (Brette et al., 2008; Sander et al., 2013), aimed at
generating myocytes for culture or electrophysiological studies, provided cells of lower yield and
involved lengthy steps of multiple centrifugations that adversely affected the cell quality and viability.
The protocols described here in Chapter 2 are reliable, cover each of the significant cardiovascular
tissues (ventricle, atria, and VSM), and importantly are very practical for acute isolation of live cells.
Isolation approaches involving cannulation of the ventricle via the BA (Kompella et al., 2021) can be
a sophisticated alternative for ventricular cardiomyocytes but require a higher degree of dexterity and
may negatively affect atrial isolation. The approach detailed in the current protocol provides a much
simpler and efficient alternative with minimal mechanical disruption and appropriate enzymatic
dissociation, followed by trituration, which may be less stressful to the cells.
Additional considerations for larval cardiac tissue isolation are: (1) In step 1.4, depending on
the age of the fish and magnification available, the tissues might be visible even before removing the
pectoral muscles, in which case, it is better to directly 'pluck' the tissues out of the fish without prior
surgery, and then clean off the non-CV tissues using superfine forceps; (2) In step 2.2, for larvae
younger than 14 days, the hearts can be used directly for electrophysiological studies without any need
for enzymatic dissociation.
As noted above, and typically true of enzymatic dissociation methods in general, it has proven
essential to use fresh buffers and enzymes each time. However, Perfusion Buffer (PB) and S1 Buffer
can be prepared in advance and stored at 4-8 °C for 1 month.
Successful tissue isolation time should not exceed ~90 s per fish, and tissues should not be
exposed to air. When dissociation takes longer, the cell quality (i.e., survival) is reduced. When
triturating tissues, care should be taken to be gentle enough to avoid generating air bubbles which also
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reduces cell quality. VSM cell isolation is sensitive to the digestion by collagenase in S3 buffer. After
the first 3 min of digestion, the tube should be taken out of the thermoshaker every minute and
examined for floating dilated and translucent tissues. Once tissue fragmentation is apparent, the
digestion step should be ceased.
It is important to note that these protocols are not extensively optimized for isolating calciumtolerant cardiomyocytes, as required for contractility studies. However, as shown, reliable recording
of cardiomyocyte action potentials can be achieved in the presence of physiological extracellular
calcium concentrations (Jou et al., 2010; Nemtsas et al., 2010). Blebbistatin, included to decouple
excitation and contraction, and improve giga-Ohm seal formation and recording efficiency in these
experiments, has previously been shown to not significantly affect the action potential parameters in
intact zebrafish hearts (Jou et al., 2010). For electrophysiology, the absolute yield of cells is also not
routinely rate-limiting. This protocol has not been optimized for yield, as might be necessary for
biochemical studies of the isolated cells. Still, the yield achieved with these methods is well suited for
electrophysiological studies and likely multiple other approaches.

5.2

Structure and Functional Properties of Cardiovascular KATP
Channels are Conserved Between Zebrafish and Mammals

Mammalian KATP channels are formed by several combinations of Kir6.1/2 and SUR1/2 subunits
(Nichols, 2006b). KATP subunit orthologues are found in all vertebrate genomes, but few studies have
investigated the structural or functional properties of KATP channels in non-mammalian vertebrates,
including fish. Emfinger et al. demonstrated that zebrafish islet β-cells express functional KATP
channels of similar subunit composition, structure and metabolic sensitivity to their mammalian
counterparts (Emfinger et al., 2017). Using PCR on cDNA isolated from various cardiovascular tissues,
we show that zebrafish cardiac and vascular smooth muscle (VSM) cells express KATP channels with
very similar composition to their mammalian counterparts, with Kir6.1/SUR2B in VSM and
Kir6.2/SUR2A in cardiomyocytes (Figs. 3.1-6). This makeup in functional KATP channels is supported
by electrophysiological studies on isolated myocytes, with the exception that we are unable to
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distinguish SUR2A and SUR2B-dependence of functional channels. Although the activity of SUR2A
and SUR2B are readily differentiated in mammals via KCO pharmacology, as SUR2B, but not SUR2A,
is activatable by diazoxide (Babenko et al., 1998a), this is not possible in the fish myocytes, given lack
of KCO activation in both cardiac and vascular KATP (see below).
Excised-patch clamp techniques confirm that zebrafish ventricular (VCM) and atrial (ACM)
myocyte sarcolemmal KATP channel properties are essentially indistinguishable from those in
mammalian ventricles, with two significant exceptions. Firstly, although the prominent SUR subunit
in rodent cardiac myocytes is SUR2 in the ventricles, but SUR1 in the atria (Flagg et al., 2007; Glukhov
et al., 2010), both atrial and ventricular channels are SUR2-dependent in the fish (Figure 3.4, 3.5). In
this regard, it is notable that in humans there is evidence for both subunits in both atrial and ventricles
(Fedorov et al., 2011). In addition, although KATP was still present in SUR1 knockout cardiomyocytes,
there was a non-significant ~50% reduction of current density in both chambers (Figure 3.4, 3.5).
Secondly, while ZF VCM and ACM channels are inhibited by ATP and MgATP, with similar
sensitivity to those in mammalian myocytes, both are insensitive to the KATP channel openers (KCOs)
pinacidil and minoxidil (Figure 3.7). Although this has not been directly demonstrated previously,
these data are consistent with prior findings that these KCOs are ineffective at eliciting KATP
conductance in whole-cell patch-clamp on myocytes from other teleost fish myocytes(Paajanen et al.,
2002), suggesting that KCO insensitivity may be common to SUR2-dependent channels in all fish.
Prior studies identified L1249 and T1253 as key residues conferring opener sensitivity in rat SUR2A
(Uhde et al., 1999; Moreau et al., 2000), and mutation of residue M1290 in hamster SUR1 to Thr (eq.
to residue 1253 in SUR2A) renders it fully activated by the other KCOs (Moreau et al., 2000).
Alignment of the zebrafish and rat SUR2A sequence shows that the equivalent Leu and Thr residues
are already present in ZF. Thus, it appears that additional unidentified residues may be involved in
KCO binding.
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5.3

Zebrafish – A Model Organism to Study Cardiovascular KATP

Recent studies have shown that GOF and LOF in KCNJ8 (Kir6.1) and ABCC9 (SUR2) underlie
human Cantu Syndrome (CS) and ABCC9-related Intellectual disability and Myopathy Syndrome
(AIMS) respectively (Harakalova et al., 2012; van Bon et al., 2012; Smeland et al., 2019). In previous
studies, it had been shown that zebrafish carrying disease-causing mutations in the equivalent kcnj8
and abcc9 loci reiterate essential features of these syndromes (Tessadori et al., 2018; Smeland et al.,
2019), and here it has been shown that each of these CS mutations causes increased VSM KATP
conductance, but cardiac channel properties are only affected in the SUR2 mutants. In mammals and
in zebrafish, the cardiac and vascular CS phenotypes are similar for both the KCNJ8 (kcnj8) and
ABCC9 (abcc9) mutations at the organismal level (Brownstein et al., 2013; Cooper et al., 2014). This has
been explained in mouse studies by the finding that cardiac pathology is a secondary response to
decreased vascular resistance (McClenaghan et al., 2020b). The current finding that the molecular
effects of SUR2 mutations are present in CM and VSM, whereas those of Kir6.1 mutants are only
present in VSM is important in suggesting that cardiac enlargement is likely to arise from the same
compensatory mechanisms in the fish as in the mouse. Confirming that the subunit composition of
cardiac and vascular myocyte KATP channels is essentially identical to the mammalian counterparts in
each case is thus an essential validation of the use of zebrafish as a model organism for studying the
pathophysiological consequences of CS, and of KATP activity changes in general.

5.4

Consequences of Reduced KATP in Pancreatic β-Cells

Insulin secretion from pancreatic β-cells is controlled by electrical activity (Nichols, 2006a). Glucose
entry leads to a metabolically generated rise in ATP/ADP concentration that initiates β-cell KATP
channel closure. This results in action potential firing and elevation of cytosolic [Ca2+], which in turn
triggers the fusion of exocytotic vesicles (Ashcroft & Rorsman, 1989). Consistent with this
understanding, Kir6.2 or SUR1 gain-of-function (GOF) mutations cause neonatal diabetes mellitus
(NDM), as a result of under-excitability and under-secretion (Koster et al., 2000; Koster & Nichols,
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2002; Gloyn et al., 2004b; Vaxillaire et al., 2004; Hattersley & Pearson, 2006; Remedi et al., 2009). On
the other hand, loss-of-function (LOF) mutations in Kir6.2 or SUR1 (Thomas et al., 1995b; Kane et
al., 1996; Nichols et al., 1996; Dunne et al., 1997; Nestorowicz et al., 1998) cause increased electrical
excitability, and human congenital hyperinsulinism (CHI) (Huopio et al., 2002; Henwood et al., 2005).
However, the long-term progression of these diseases is complicated. First, NDM may be only
transient (TNDM); even though KATP GOF is permanent. Second, although partial loss of mouse βcell KATP increases excitability and insulin secretion at lower glucose levels (Koster & Nichols, 2002;
Remedi et al., 2006), insulin secretion is dramatically reduced in mice with more complete loss of KATP
(Miki et al., 1997; Miki et al., 1998; Seghers et al., 2000; Shiota et al., 2002; Remedi et al., 2004; Shimomura
et al., 2013). The same outcome is seen in mice that express dominant-negative subunits specifically in
β-cells (Remedi et al., 2004; Oduori et al., 2020). At high glucose, insulin secretion from human CHI
islets at high glucose, is also lower than in normal individuals (Henquin et al., 2011; Li et al., 2017a),
and as in mice with complete loss of KATP, CHI symptoms decrease with age (Mazor-Aronovitch et
al., 2007; Banerjee et al., 2011; Martinez et al., 2016; Salomon-Estebanez et al., 2016), and some patients
become glucose intolerant later in life (Huopio et al., 2003; Kapoor et al., 2013). What causes these
secondary disease consequences is not known, but the results presented in Chapter 4 provide
intriguing hypotheses in this regard.
Firstly, they indicate that the GOF Kir6.2[R201H] mutation, when expressed from the
genomic locus, leads to reduced levels of KATP channel density, in zebrafish heart and pancreatic βcells. In humans, this common NDM mutation can be associated with TNDM, and these results raise
the possibility that KATP channel overactivity, resulting from the loss of inhibitory ATP sensitivity, may
be counteracted by reduced channel expression. Further experiments would be necessary to confirm
whether this occurs at all ages or, is perhaps a secondary down-regulation at transcriptional or
translational level, in response to early hyperglycemia.
Secondly, they indicate that an unidentified ATP-insensitive, high conductance (~240pS)
channel, which is not detected in normal WT beta cells, is clearly present in several conditions in which
β-cell KATP density is reduced. These channels, which may be encoded by members of the Kv family
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of subunits, are distinct from the ~300 pS BK channels that are present in all conditions and highly
Ca2+-sensitive. If the preliminary conclusion that the expression of these channels is up-regulated in
conditions of reduced KATP is validated, then they provide an exciting possibility that by adding
hyperpolarizing conductance, they may contribute to the remission of CHI.
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